Cargando…

FRI572 Teprotumumab In Unexplored Presentation Of Thyroid Eye Disease

Disclosure: M.T. Torres Torres: None. A.N. Gonzalez Bossolo: None. M.M. Mangual Garcia: None. Thyroid eye disease (TED) is an autoimmune disease of the orbital soft tissue associated with facial disfigurement, diminished quality of life, and potentially vision-threatening consequences that can occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres Torres, Marina T, Gonzalez Bossolo, Alex N, Mangual Garcia, Michelle Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554384/ http://dx.doi.org/10.1210/jendso/bvad114.1915

Ejemplares similares

SUN-627 Unexpected Presentation of a Primary Thyroid T-Cell Lymphoma
por: Vergne-Santiago, Norma, et al.
Publicado: (2019)

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023)

SAT-577 Managing Patients with Contrasting Thyroid Dysfunction: Is Definitive Treatment Necessary?
por: Zayas, Francisco, et al.
Publicado: (2019)

SAT-617 Lingual Thyroid Gland: It's Time for Awareness
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019)

RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022)

PSAT261 Use of Steroids Pre- and Post-Teprotumumab in Thyroid Eye Disease Patients
por: Holt, Robert J, et al.
Publicado: (2022)

LBSAT238 Teprotumumab Reduces Orbital Fat And Muscle Volume In Patients With Thyroid Eye Disease
por: Ugradar, Shoaib
Publicado: (2022)

SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023)

A Case of Diffuse Sclerosing Variant of Papillary Thyroid Cancer: An Aggressive Variant Presenting With Recurrent Locoregional Nodal Disease
por: Cruz, Yaniris García, et al.
Publicado: (2021)

Hearing Loss and Teprotumumab
por: Kossler, Andrea, et al.
Publicado: (2021)

PSAT265 Blood Glucose in Thyroid Eye Disease (TED) in Patients treated with Teprotumumab: Clinical Trials Data
por: Smith, Terry J, et al.
Publicado: (2022)

FRI570 Repatha Induced Thyroid Storm
por: Sepulveda-Garcia, Luis Ruben, et al.
Publicado: (2023)

FRI541 The Epidemiology Of Thyroid Eye Disease In Olmsted County, Minnesota
por: Rachmasari, Kharisa N, et al.
Publicado: (2023)

SUN-572 Hyperthyroidism Refractory to Methimazole
por: Eren, Aysegul, et al.
Publicado: (2019)

Graves’ Disease Induced Severe Hypercalcemia
por: Lugo Lopez, Zahira Marie, et al.
Publicado: (2021)

FRI499 The Importance Of Identifying Atypical Presentation Of Thyroid Storm
por: Hernan Sacoto, Daniel, et al.
Publicado: (2023)

OR27-04 Efficacy And Safety Results From The Randomized, Placebo-controlled Multicenter Trial With Teprotumumab In Chronic-Low Clinical Activity Score Thyroid Eye Disease Patients
por: Douglas, Raymond S, et al.
Publicado: (2023)

OR26-02 VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor In Development For Thyroid Eye Disease (TED), Binds To A Distinct Epitope From Teprotumumab
por: Bedian, Vahe, et al.
Publicado: (2023)

MON-572 Assessing Error in the Referencing of Thyroid Nodule Size by Longest Dimension (LD) and by Volume (Vol)
por: Al Anbari, Raghda, et al.
Publicado: (2019)

SAT455 A Randomized, Quadruple-masked, Placebo-controlled, Multicenter Trial To Evaluate The Efficacy And Safety Of Teprotumumab In Patients With Chronic (Inactive/Low CAS) Thyroid Eye Disease
por: Douglas, Raymond S, et al.
Publicado: (2023)

FRI561 The Thyroid Trifecta
por: Kachhadia, Palak, et al.
Publicado: (2023)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

SAT-432 Pharmacokinetics (PK) and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Blocking Antibody, in Active Thyroid Eye Disease (TED)
por: Xin, Yan, et al.
Publicado: (2020)

SAT-572 Morphological and Molecular Alterations in Thyroid Neoplastic Cells Infected by Epstein-Barr Virus May Be Associated to Tumor Evolution
por: Almeida, Jacqueline Fátima, et al.
Publicado: (2019)

FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
por: Maria Bignoli, Daniela Laura, et al.
Publicado: (2023)

FRI497 Thyroid Storm And Recurrent Myopericarditis
por: Gomez D' Aza, Danelly J, et al.
Publicado: (2023)

SAT471 Hearing-Related Adverse Events in Teprotumumab Oncology Clinical Trials
por: Smith, Terry J, et al.
Publicado: (2023)

FRI483 Changes In Thyroid Function Test With Tirzepatide Use In Patients With Hypothyroidism
por: Kaylee Yu, Gayoung, et al.
Publicado: (2023)

OR18-01 Effect of Teprotumumab on Proptosis Reduction Across Various Demographic Sub-Groups
por: Kahaly, George J, et al.
Publicado: (2020)

FRI491 The Impact Of Insulin Resistance On Thyroid Function In Pregnancy
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2023)

FRI486 Overactive Thyroid And Overactive Mind - An Intervened Relationship
por: Bilichodu Rangappa, Sushma, et al.
Publicado: (2023)

FRI522 Impact Of TIRADS Score On Thyroid Nodule Biopsy
por: Blessing Adeniran, Uchechi, et al.
Publicado: (2023)

FRI535 Quality Of Life And Symptomatology In Patients With Autoimmune Thyroiditis
por: Miguel Pereira, Luis, et al.
Publicado: (2023)

FRI501 A Rare Case Of Acute Suppurative Thyroiditis
por: Gupta, Vishaal
Publicado: (2023)

FRI536 Association Between Thyroid Cancer And Thyroid Autoimmunity: A Systematic Review
por: Pessoa, Bruna, et al.
Publicado: (2023)

Cardiac Metastasis From Anaplastic Thyroid Carcinoma
por: Gonzalez, Michelle N Garcia, et al.
Publicado: (2021)

SAT572 Concomitant Metastatic Hurthle Cell Carcinoma And Rectal Cancer, Challenges In Diagnosis And Management
por: Khurram, Daniyeh, et al.
Publicado: (2023)

Rapidly Progressive Cognitive Decline and Varicella Zoster Blisters Associated With Teprotumumab in 2 Patients With Graves’ Orbitopathy
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

FRI563 Subacute Thyroiditis Is An Uncommon Cause Of Pyrexia Of Unknown Origin
por: Luke, Nathasha, et al.
Publicado: (2023)

FRI496 A Rare Case Of Thyroid Hormone Resistance Beta
por: Kaur Rai, Harpreet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_la834j4bbvidtg3vf1du28jc53